Skip to main content

The Relationship between Pituitary Adenomas and the Diencephalon

  • Chapter
Surgery of the Diencephalon

Part of the book series: Contemporary Perspectives in Neurosurgery ((COPENEU))

  • 54 Accesses

Abstract

Pituitary tumors are discussed in some depth throughout this volume. This chapter will focus on a few ways in which pituitary tumors interact with the hypothalamic and diencephalic regions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Daughaday WH. Cushing’s disease and basophilic microadenomas. N Engl J Med 1984; 310:919–920.

    Article  PubMed  CAS  Google Scholar 

  2. Molitch ME: ACTH-secreting adenomas, in Post KP, Jackson IMD, Reichlin S (eds): Pituitary Adenoma. New York, Plenum Press, 1980, pp 119–140.

    Chapter  Google Scholar 

  3. Schnall AM, Brodkey JS, Kaufman B, et al: Pituitary function after removal of pituitary microadenomas in Cushing’s disease. J Clin Endocrinol Metab 1978; 17: 410–417.

    Article  Google Scholar 

  4. Boggan JE, Tyrell JB, Wilson CB: Transsphenoidal microsurgical management of Cushing’s disease. Report of 100 cases. J Neurosurg 1983; 59: 195–200.

    Article  PubMed  CAS  Google Scholar 

  5. Krieger DT, Amorosia L, Linich F: Cyproheptadine-induced remission of Cushing’s disease. N Engl J Med 1975; 293: 893–896.

    Article  PubMed  CAS  Google Scholar 

  6. Findling JW, Aron DC, Tyrell JB, et al: Selective venous sampling for ACTH in Cushing’s syndrome. Ann Intern Med 1981; 94: 647–652.

    PubMed  CAS  Google Scholar 

  7. Oldfield EH, Chrousos GP, Schulte HM, et al: Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sampling. N Engl J Med 1985; 312: 100–103.

    Article  PubMed  CAS  Google Scholar 

  8. Hardy J: Cushing’s disease: 50 years later. Can J Neurol Sci 1980; 9: 375–380.

    Google Scholar 

  9. Lamberts SW, Uitterlinder P, Verschoor L, et al: Long-term treatment of acromegaly with somatostatin analogue SMS 201–995. N Engl J Med 1985; 313: 1576–1580.

    Article  PubMed  CAS  Google Scholar 

  10. Lindholm J, Riishede J, Vestergaard S, et al: No effect of bromocriptine in acromegaly: a controlled trial. N Engl J Med 1981; 304: 1450–1454.

    Article  PubMed  CAS  Google Scholar 

  11. Reichlin S, Molitch ME: Neuroendocrine aspects of pituitary adenomas. in Cammani F, Muller EE (eds): Pituitary Hyperfunction: Physiopathology and Clinical Aspects. New York, Raven Press, 1984, pp 47–70.

    Google Scholar 

  12. Molitch ME, Goodman RH, Post KD et al: Surgical cure of prolactinoma reverses abnormal prolactin response to carbidopa/L-dopa. J Clin Endocrinol Metab 1982; 55: 1118–1123.

    Article  PubMed  CAS  Google Scholar 

  13. Vertosick FT: Role of defective dopaminergic inhibition of prolactin secretion in the pathogenesis of prolactinoma. Neurosurgery 1985; 16: 261–266.

    Article  PubMed  Google Scholar 

  14. Goodman RH, Molitch ME, Post KD, et al: Prolactin secreting adenomas in the male, in Post KD, Jackson IMD, Reichlin S (eds): The Pituitary Adenoma. New York, Plenum Press, 1980, pp 91–108.

    Chapter  Google Scholar 

  15. Landolt AM: Surgical treatment of pituitary prolactinomas: postoperative prolactin and fertility in seventy patients. Fertil Steril 1981; 35: 620–625.

    PubMed  CAS  Google Scholar 

  16. Serri O, Somma M, Rasio E, et al: Prolactin secreting pituitary adenomas in males: transsphenoidal microsurgical treatment. Can Med Assoc J 1980; 122: 1007–1013.

    PubMed  CAS  Google Scholar 

  17. McGregor AM, Scanlon MF, Hall K, et al: Reduction in size of a pituitary tumor by bromocriptine therapy. N Engl J Med 1979; 300: 291–293.

    Article  PubMed  CAS  Google Scholar 

  18. Thorner MO, Martin WH, Rogol AD, et al: Rapid regression of pituitary prolactinomas during bromocriptine treatment. J Clin Endocrinol Metab 1980; 51: 438–445.

    Article  PubMed  CAS  Google Scholar 

  19. Landolt AM, Minder H, Osterwalder V, et al: Bromocriptine reduces the size of cells in prolactinsecreting pituitary adenomas. Experientia 1983; 39: 625.

    Article  PubMed  CAS  Google Scholar 

  20. Tindall GT, Kovacs K, Horvath E, et al: Human prolactin-producing adenomas and bromocriptine: a histological immunocytochemical ultrastructural and morphometric study. J Clin Endocrinol Metab 1982; 55: 1178–1183.

    Article  PubMed  CAS  Google Scholar 

  21. Weiss MH, Wycoff RR, Yadley R, et al: Bromocriptine treatment of prolactin-secreting tumors: surgical implications. Neurosurgery 1983; 12: 640–642.

    Article  PubMed  CAS  Google Scholar 

  22. Thonier MO, Perryman RL, Rogol AD, et al: Rapid changes of prolactinoma volume after withdrawal and reinstitution of bromocriptine. J Clin Endocrinol Metab 1981; 53: 480–483.

    Article  Google Scholar 

  23. Shucart WA: Implications of very high serum prolactin levels associated with pituitary tumors. J Neurosurg 1980; 52: 226–228.

    Article  PubMed  CAS  Google Scholar 

  24. Laws ER Jr, Kern EB: Pituitary tumors treated by transnasal microsurgery: 7 years of clinical experience with 539 patients, in Sano K, Takakura K, Fukushima T (eds): Functioning Pituitary Adenoma: Proceedings of the First Workshop on Pituitary Adenomas. Tokyo, 1980, pp. 25–34.

    Google Scholar 

  25. Serri O, Rasio E, Beauregard H, et al: Recurrence of hyperprolactinoma after selective transsphenoidal adenomectomy in women with prolactinomas. N Engl J Med 1983; 309: 280–283.

    Article  PubMed  CAS  Google Scholar 

  26. Rodman EF, Molitch ME, Post KD et al: Long-term follow-up of transsphenoidal selective adenomectomy for prolactinomas. JAMA 1984; 252: 921–924.

    Article  PubMed  CAS  Google Scholar 

  27. Vance ML, Evans WS, Thonier MO: Bromocriptine. Ann Intern Med 1984; 100: 78–91.

    PubMed  CAS  Google Scholar 

  28. Krupp P, Turkalj I: Surveillance of Parlodel (bromocriptine) in pregnancy and offspring, in Jacobs HS, Harrison RF, Bonnar J, et al (eds): Prolactinomas and Pregnancy. Lancaster, England, MTP Press, 1983, pp 45–50.

    Google Scholar 

  29. Molitch ME, Elton RL, Blackwell RE: Bromocriptine as primary therapy for prolactin-secreting macroadenomas: Results of a prospective multicenter study. J Clin Endocrinol Metab 1985; 60: 698–705.

    Article  PubMed  CAS  Google Scholar 

  30. Luzzi A, Dallabonzana D, Oppizzi G: Low doses of dopamine agonists in the long-term treatment of macroprolactinomas. N Engl J Med 1985; 313: 656–659.

    Article  Google Scholar 

  31. Moriondo P, Travaglini P, Nissim M, et al: Bromocriptine treatment of microprolactinomas: Evidence of stable prolactin decrease after drug withdrawal. J Clin Endocrinol Metab 1985; 60: 764–772.

    Article  PubMed  CAS  Google Scholar 

  32. Molitch ME: Pregnancy and the hyperprolactinemic woman. N Engl J Med 1985; 312: 1364–1370.

    Article  PubMed  CAS  Google Scholar 

  33. Gemzell C, Wang CF: Outcome of pregnancy in women with pituitary adenoma. Fertil Steril 1979; 31: 363–372.

    PubMed  CAS  Google Scholar 

  34. Konopka P, Taymond JP, Merceron RE, et al: Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas. Am J Obstet Gynecol 1983; 146: 935–938.

    PubMed  CAS  Google Scholar 

  35. Maeda T, Ushiroyama T, Okuda K, et al: Effective bromocriptine treatment of a pituitary macroadenoma during pregnancy. Obstet Gynecol 1983; 61: 117–121.

    PubMed  CAS  Google Scholar 

  36. Gen M, Uozumi T, Ohta M, et al: Necrotic changes in prolactinomas after long term administration of bromocriptine. J Clin Endocrinol Metab 1984; 59: 463–470.

    Article  PubMed  CAS  Google Scholar 

  37. Landolt AM, Keller PJ, Froesch ER, et al: Bromocriptine: does it jeoparadize the result of later surgery for prolactinomas? Lancet 1982; 2: 657–658.

    Article  PubMed  CAS  Google Scholar 

  38. Landolt AM, Osterwalder V: Perivascular fibrosis in prolactinomas: is it increased by bromocriptine ? J Clin Endocrinol Metal, 1984; 58: 1179–1183.

    Article  CAS  Google Scholar 

  39. Marcovitz S, Hardy J: Combined medical and surgical treatment of prolactin-producing pituitary tumors. Semin Reprod Endocrinol 1984; 2: 73–81.

    Article  Google Scholar 

  40. Weiss MH: Medical and surgical management of function in pituitary tumors. Clin Neurosurg 1981; 28: 374–383.

    PubMed  CAS  Google Scholar 

  41. Weiss MH, Teal J, Gott P, et al: Natural history of microprolactinomas: six year follow-up. Neurosurgery 1983; 12: 180–183.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Plenum Publishing Corporation

About this chapter

Cite this chapter

Post, K.D. (1989). The Relationship between Pituitary Adenomas and the Diencephalon. In: Holtzman, R.N.N., Stein, B.M. (eds) Surgery of the Diencephalon. Contemporary Perspectives in Neurosurgery. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5586-1_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5586-1_16

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5588-5

  • Online ISBN: 978-1-4684-5586-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics